Independent report

Raspberry leaf tea

Risk assessment of of the consumption of raspberry leaf tea during pregnancy, supporting food safety advice on potential risks to maternal and offspring health.

• From: Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment
• Published: 13 November 2024

Documents

Statement on the potential health effects of raspberry leaf tea in the maternal diet

HTML

Statement on the potential health effects of raspberry leaf tea in the maternal diet

PDF, 616 KB, 37 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email COT@food.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Statement on the potential health effects of raspberry leaf tea in the maternal diet: Lay summary

HTML

Statement on the potential health effects of raspberry leaf tea in the maternal diet: Lay summary

PDF, 187 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email COT@food.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

• Scope: This statement assesses the potential health effects of raspberry leaf consumption during pregnancy as part of the maternal diet. It reviews human, animal and in vitro evidence on safety, including effects on the mother, pregnancy outcomes, fetal and offspring development, uterine contractility, drug–herb interactions and potential contaminants. The report also considers patterns of use, estimated dietary exposure from tea, tablets and tinctures, and the limitations and uncertainties in the available evidence, noting that no health‑based guidance value could be established due to data gaps.
• Committee: COT.
• Type: Statement.
• Statement number: 2024/06.
• Date: November 2024

Published 13 November 2024